Actively Recruiting

Phase Not Applicable
Age: 40Years +
All Genders
NCT06264076

Ligament Balancing in Total Knee Arthroplasty

Led by Oslo University Hospital · Updated on 2025-11-25

40

Participants Needed

2

Research Sites

139 weeks

Total Duration

On this page

Sponsors

O

Oslo University Hospital

Lead Sponsor

V

Vestre Viken Hospital Trust

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this interventional pilot study is to evaluate if performing ligament balancing on the medial collateral ligament (MCL) in a more systematical manner with a novel instrument can produce more objective and repeatable ligament lengthening in Total Knee Arthroplasty. The main questions it aim to answer are: 1. Is it feasible to perform systematic ligament balancing on the MCL using a novel instrument? 2. Can a novel instrument for ligament balancing acquire more objective and repeatable results, without risk of injury? Participants must consent prior to the surgery, but inclusion is only done once ligament balancing is indicated during surgery. Patients will be follow-up as standard protocol for Total Knee Arthroplasty patients at the hospital.

CONDITIONS

Official Title

Ligament Balancing in Total Knee Arthroplasty

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women over 40 years of age that require total knee arthroplasty
  • Diagnosis of idiopathic osteoarthrosis, osteonecrosis, or avascular osteonecrosis
  • Generally healthy without significant health issues
Not Eligible

You will not qualify if you...

  • Under 40 years of age
  • Pregnant
  • Previous revisions or reoperations on the knee
  • Significant prior injury to the knee
  • Isolated patellofemoral osteoarthrosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Bærum Hospital, Vestre Viken Hospital Trust

Bærums verk, Akershus, Norway, 1346

Completed

2

Oslo University Hospital, Ullevaal

Oslo, Oslo, Norway, 0450

Actively Recruiting

Loading map...

Research Team

L

Lars HW Engseth, MD

CONTACT

J

Jarle Vik, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here